ArticleFunction (Oxford, England)2025
Sphingosine-1-Phosphate Receptor 2 Promotes Renal Microvascular Constriction and Kidney Injury Following Renal Ischemia-Reperfusion in Rats.
Article in Function (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Ischemia-reperfusion (IR) induced acute kidney injury (AKI) features increased renal vascular resistance, which is predominantly regulated by adjustments in afferent arteriolar diameter. Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, is a potent vasoconstrictor in afferent arterioles. We hypothesized that IR enhanced afferent arteriolar sensitivity to S1P-induced vasoconstriction, thus contributing to renal microvascular dysfunction and kidney injury in AKI. The impact of IR on afferent arteriolar reactivity to S1P was assessed using the in vitro blood-perfused juxtamedullary nephron preparation in male rats subjected to 60 min of bilateral renal arterial ischemia followed by 24 h of reperfusion. Baseline diameter of afferent arterioles declined significantly following IR. S1P evoked concentration-dependent vasoconstriction in both sham and IR rats. However, the S1P concentration-response curve left-shifted after IR and its EC50 reduced by 8-fold (P < 0.05), suggesting enhanced afferent arteriolar reactivity to S1P. S1P receptor 2 (S1PR2) blockade with JTE-013 increased arteriolar diameter by 38 ± 7% following IR contrasted to a 9 ± 3% increase in sham rats (P < 0.05), indicating that endogenous S1P exerts a significant impact on afferent arteriolar tone after IR. Furthermore, IR upregulated mRNA and protein of S1PR2 in isolated preglomerular microvessels and elevated S1P content in kidney homogenates. Conversely, following IR, vasoresponsiveness to S1PR1 agonist, sphingosine, endothelin-1, norepinephrine, and angiotensin II did not differ from sham controls. JTE-013 treatment reduced plasma creatinine, tubular damage, and kidney ROS accumulation in IR rats. These data establish that IR enhances renal microvascular S1P-S1PR2 signaling and promotes kidney sphingolipid metabolites that could negatively affect kidney tissue perfusion, leading to AKI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.